STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13D/A] Advanced Flower Capital Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Amendment No. 2 to a Schedule 13D reports that Leonard M. Tannenbaum beneficially owns 6,241,981 shares of Advanced Flower Capital Inc., representing 27.6% of the 22,594,541 shares outstanding as of August 13, 2025. The filing states Mr. Tannenbaum acquired additional Common Stock in multiple open market purchases since his prior Schedule 13D/A on July 2, 2024, using personal funds; those transactions are said to be listed on Schedule A. His holdings include 4,148,243 shares held directly, 186,780 shares of restricted stock and 1,906,958 shares issuable upon exercise of options exercisable within 60 days. The filing disclaims beneficial ownership of 180,400 shares held by the Tannenbaum Family Foundation and 211,827 shares held by his spouse.

Positive

  • Significant accumulation: Reporting person increased holdings via open market purchases, signaling continued insider investment
  • Transparent breakdown: Filing discloses direct shares, restricted stock, and options exercisable within 60 days (totaling 6,241,981 shares)

Negative

  • Concentrated ownership: A 27.6% stake may raise governance and control implications for other shareholders
  • Schedule A not included here: Transaction-level details (dates and amounts) referenced but not provided in the supplied content

Insights

TL;DR: Reporting person holds a large, near-controlling 27.6% stake largely via direct shares and exercisable options.

The disclosed 6.24 million-share position, including nearly 1.91 million options exercisable within 60 days, meaningfully concentrates economic and voting exposure in one individual. The purchases were made with personal funds in open market transactions and were material enough to require amendment. For investors this signals continued insider accumulation and potential influence on corporate strategy or control dynamics; however, no transaction prices, dates, or Schedule A detail are provided here to assess timing or cost basis.

TL;DR: A single holder at 27.6% raises governance and influence considerations for Advanced Flower Capital.

Such a substantial ownership stake can affect board composition, shareholder proposals, and strategic outcomes. The filing appropriately identifies shares excluded from beneficial ownership (foundation and spouse). The amendment reports incremental open-market accumulation but does not include Schedule A detail in the provided text, limiting assessment of whether purchases alter voting dynamics over time.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
This Amendment No. 2 to Schedule 13D (this "Amendment No. 2") amends and supplements the Schedule 13D originally filed with the Securities and Exchange Commission (the "SEC") by Leonard M. Tannenbaum (the "Reporting Person") with respect to Advanced Flower Capital Inc. (the "Issuer") on April 2, 2021 (the "Schedule 13D"), as amended by Amendment No. 1 to Schedule 13D filed on July 2, 2024. This Amendment No. 2 is being filed solely to report purchases of Common Stock that in aggregate exceeded 1% of the Issuer's outstanding Common Stock since the Reporting Person's last Schedule 13D/A filing, while the Reporting Person's overall percentage ownership did not increase by more than 1%. The Schedule 13D is hereby amended and supplemented to include the information set forth herein. Capitalized terms not defined herein have the meanings given to such terms in the Schedule 13D. Except as set forth herein, the Schedule 13D is unmodified. Lines 7 and 9 consist of 4,148,243 shares of Common Stock, par value $0.01 per share, of the Issuer (the "Common Stock") held directly by the Reporting Person and 186,780 shares of restricted stock held by the Reporting Person and 1,906,958 shares of Common Stock issuable upon exercise of stock options held directly by the Reporting Person and exercisable within 60 days. Excludes (i) 180,400 shares of Common Stock held by the Tannenbaum Family Foundation (formerly known as the Leonard M. Tannenbaum Foundation), for which the Reporting Person serves as the President, over which the Reporting Person disclaims beneficial ownership, except to the extent of his pecuniary interest and (ii) 211,827 shares of Common Stock (including restricted stock and shares underlying stock options exercisable within 60 days) held by Ms. Robyn Tannenbaum, the Reporting Person's spouse, over which the Reporting Person disclaims beneficial ownership. Line 13 is based on the 22,594,541 shares of Common Stock outstanding as of August 13, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q, filed with the SEC on August 14, 2025.


SCHEDULE 13D


Leonard M. Tannenbaum
Signature:/s/ Leonard M. Tannenbaum
Name/Title:Leonard M. Tannenbaum
Date:08/26/2025
Advanced Flower Capital Inc

NASDAQ:AFCG

AFCG Rankings

AFCG Latest News

AFCG Latest SEC Filings

AFCG Stock Data

65.75M
16.08M
24.6%
28.66%
6.41%
REIT - Mortgage
Real Estate
Link
United States
WEST PALM BEACH